雪崩掩埋近23小时致严重低体温与严重冻伤后恢复良好:一例病例报告
报告一名53岁健康男性滑雪者被雪崩掩埋近23小时,环境温度-8°C、海拔2300 m,初诊核心体温23.1°C、GCS 11分(E4V2M5)、四肢冻伤征象。在ICU经主动外部强制空气复温后,双足和左手一度冻伤消退,右手全部手指出现三至四度冻伤。核心体温达约36°C后启动外周动脉导管定向阿替普酶溶栓、静脉伊洛前列素、布洛芬、地塞米松及右侧连续腋窝阻滞区域交感神经阻滞等积极冻伤治疗。10个月后无组织丢失,但需普瑞巴林治疗神经病理性疼痛。作者认为低体温治疗应优先,完全复温后尽早开始冻伤治疗,但联合治疗的最佳剂量和时机尚需更多证据。
要点
- 雪崩掩埋近23小时、核心体温23.1°C者经ICU主动外部强制空气复温可存活,复温至约36°C是启动冻伤治疗的前提。
- 复温后双足和左手一度冻伤征象消失,右手全部手指显现三至四度冻伤,提示冻伤评估需在复温后重新进行。
- 核心体温达约36°C后采用外周动脉导管定向阿替普酶溶栓、静脉伊洛前列素、布洛芬、地塞米松及右侧连续腋窝阻滞区域交感神经阻滞。
- 10个月随访无组织丢失,但仍需普瑞巴林治疗神经病理性疼痛。
- 作者认为低体温治疗应优先,完全复温后尽早开始冻伤治疗;低体温患者药物代谢不可预测,联合治疗无推荐。
适用人群与场景
- 既往健康的53岁男性滑雪者,被雪崩掩埋于海拔2300 m、环境温度-8°C近23小时,初诊核心体温23.1°C、GCS 11分(E4V2M5)、自主呼吸、四肢冻伤征象。
诊断标准与关键阈值
- 初诊核心体温23.1°C,GCS 11分(Eye 4, Verbal 2, Motor 5),存在四肢冻伤征象。
- 复温后双足和左手一度冻伤临床征象消失,右手全部手指出现三至四度冻伤。
- 核心体温达约36°C作为启动积极冻伤治疗的时机。
处置流程与药物剂量
- 救援后转入ICU行主动外部强制空气复温。
- 核心体温达约36°C后启动积极冻伤治疗:外周动脉导管定向阿替普酶溶栓、静脉伊洛前列素、布洛芬、地塞米松,以及右侧连续腋窝阻滞行区域交感神经阻滞。
- 作者认为应优先进行低体温治疗,并在患者完全复温后尽早开始冻伤治疗。
- 10个月随访时因神经病理性疼痛给予普瑞巴林治疗。
红旗征与不能漏的情况
- 严重意外低体温(核心体温23.1°C)合并严重冻伤,长期后遗症风险高。
- 低体温患者药物代谢不可预测,且严重低体温合并冻伤无联合治疗推荐。
研究设计与关键结果
- 病例报告:53岁男性滑雪者被雪崩掩埋近23小时,初诊核心体温23.1°C、GCS 11分(E4V2M5),四肢冻伤征象。
- ICU主动外部强制空气复温后,双足和左手一度冻伤征象消失,右手全部手指显现三至四度冻伤。
- 核心体温约36°C后予外周动脉导管定向阿替普酶溶栓、静脉伊洛前列素、布洛芬、地塞米松及右侧连续腋窝阻滞区域交感神经阻滞。
- 10个月后无组织丢失,但需普瑞巴林治疗神经病理性疼痛。
证据类型、等级与局限
- 病例报告。
- 作者指出严重意外低体温合并严重冻伤罕见且处理困难,低体温患者药物代谢不可预测,无联合治疗推荐。
- 作者指出需要更多证据确定严重低体温患者冻伤治疗的最佳剂量和启动时机,未来治疗推荐应考虑这一点。
对床旁实践的改变
- 对严重低体温合并冻伤的雪崩受害者,作者认为应优先处理低体温,完全复温后再尽早开始冻伤治疗。
- 冻伤评估应在复温后进行,本例复温后双足和左手一度冻伤征象消失而右手显现三至四度冻伤。
- 作者指出低体温患者药物代谢不可预测,严重低体温合并冻伤无联合治疗推荐,用药剂量需个体化考量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Accidental hypothermia with severe frostbite is a rare combination of injuries with a high risk for long-term sequelae. There are widely accepted recommendations for the management of avalanche victims and for frostbite treatment, but no recommendation exists for the treatment of frostbite in severe hypothermic patients, specifically for the management of hypothermic avalanche victims presenting with frostbite.
CASE PRESENTATION: We present a case of a previously healthy, 53-year-old male skier who was critically buried by an avalanche at 2300 m of altitude at an ambient temperature of - 8 °C for nearly 23 h. The victim was found with the right hand out of the snow and an air connection to outside. He was somnolent with Glasgow Coma Scale 11 (Eye 4, Verbal 2, Motor 5) and spontaneously breathing, in a severely hypothermic state with an initial core temperature of 23.1 °C and signs of cold injuries in all four extremities. After rescue and active external forced air rewarming in the intensive care unit, the clinical signs of first-degree frostbite on both feet and the left hand vanished, while third- to fourth-degree frostbite injuries became apparent on all fingers of the right hand. After reaching a core body temperature of approximately 36 °C, aggressive frostbite treatment was started with peripheral arterial catheter-directed thrombolysis with alteplase, intravenous iloprost, ibuprofen, dexamethasone and regional sympathicolysis with a right-sided continuous axillary block. After ten months, the patient had no tissue loss but needed neuropathic pain treatment with pregabalin.
CONCLUSION: The combination of severe accidental hypothermia and severe frostbite is rare and challenging, as drug metabolism is unpredictable in a hypothermic patient and no recommendations for combined treatment exist. There is general agreement to give hypothermia treatment the priority and to begin frostbite treatment as early as possible after full rewarming of the patient. More evidence is needed to identify the optimal dosage and time point to initiate treatment of frostbite in severely hypothermic patients. This should be taken into consideration by future treatment recommendations.
参考来源
- Gruber E, Oberhammer R, Brugger H, et al. Prolonged critical avalanche burial for nearly 23 h with severe hypothermia and severe frostbite with good recovery: a case report. Scand J Trauma Resusc Emerg Med. 2024. PMID: 38347576. doi:10.1186/s13049-024-01184-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。